Solo Pace announced today that it received FDA clearance for its SoloPace Control System for temporary pacing in TAVR ...

Solo Pace Incorporated, an emerging medical technology company, announced both FDA Clearance and First-In-Human use of their SoloPace Control System for temporary pacing in Transcatheter Aortic Valve ...

Solo Pace Incorporated, an emerging medical technology company, announced both FDA Clearance and First-In-Human use of their SoloPace Control System for temporary pacing in Transcatheter Aortic Valve ...

Both patients were discharged without complications the next day. The Siegel valve represents several firsts in TAVR: 8 French delivery sheath allowing less invasive procedures and broader patient ...

Both patients were discharged without complications the next day. The Siegel valve represents several firsts in TAVR: 8 French delivery sheath allowing less invasive procedures and broader patient ...

Edwards Lifesciences Corporation ( NYSE: EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Mark Wilterding - SVP, Global Finance Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - ...

This procedure is known as Transcatheter Aortic Valve Replacement (TAVR) or Transcatheter Aortic Valve Implantation (TAVI). Since then, many studies have been conducted across all risk categories ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

For young Indians grappling with aortic valve disease, the Ross procedure offers a lifeline—one that restores vitality ...

1,414 patients were randomized, with 730 receiving TAVR with either a Medtronic Evolut ... Any forward-looking statements are subject to risks and uncertainties such as those described in ...